Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Change in Account Payables: 2021-2025

Historic Change in Account Payables for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Sep 2025 value amounting to -$2.7 million.

  • Kiniksa Pharmaceuticals International's Change in Account Payables fell 399.45% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.0 million, marking a year-over-year decrease of 128.01%. This contributed to the annual value of -$6.3 million for FY2024, which is 1917.29% down from last year.
  • Per Kiniksa Pharmaceuticals International's latest filing, its Change in Account Payables stood at -$2.7 million for Q3 2025, which was down 139.37% from $6.9 million recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Change in Account Payables ranged from a high of $7.2 million in Q4 2023 and a low of -$6.5 million during Q1 2023.
  • Moreover, its 3-year median value for Change in Account Payables was $62,000 (2025), whereas its average is -$154,091.
  • Per our database at Business Quant, Kiniksa Pharmaceuticals International's Change in Account Payables surged by 2,472.00% in 2022 and then tumbled by 529.57% in 2023.
  • Kiniksa Pharmaceuticals International's Change in Account Payables (Quarterly) stood at $250,000 in 2021, then spiked by 2,472.00% to $6.4 million in 2022, then grew by 12.50% to $7.2 million in 2023, then crashed by 186.87% to -$6.3 million in 2024, then plummeted by 399.45% to -$2.7 million in 2025.
  • Its Change in Account Payables was -$2.7 million in Q3 2025, compared to $6.9 million in Q2 2025 and $62,000 in Q1 2025.